Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents

被引：2
|
作者：
Cook, G. [1 ]
机构：
[1] Univ Leeds, Dept Haematol, Transplant Immunol Grp, Sect Expt Haematol,Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷 / 10期
关键词：
HIGH-DOSE MELPHALAN; BORTEZOMIB; DEXAMETHASONE; THERAPY; PHASE-2; RELAPSE; TRIAL;
D O I：
10.1038/bmt.2015.175
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 50 条
  • [1] Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents
    G Cook
    Bone Marrow Transplantation, 2015, 50 : 1269 - 1270
  • [2] The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma
    Miller, Kevin C.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Lacy, Martha Q.
    Dispenzieri, Angela A.
    Dingli, David
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Muchtar, Eli
    Hogan, William J.
    Kumar, Shaji K.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2039 - 2050
  • [3] The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma
    Kevin C. Miller
    Morie A. Gertz
    Francis K. Buadi
    Suzanne R. Hayman
    Martha Q. Lacy
    Angela A. Dispenzieri
    David Dingli
    Prashant Kapoor
    Wilson I. Gonsalves
    Taxiarchis Kourelis
    Eli Muchtar
    William J. Hogan
    Shaji K. Kumar
    Bone Marrow Transplantation, 2019, 54 : 2039 - 2050
  • [4] Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
    Shimazaki, Chihiro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 14 - 15
  • [5] Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents
    D Tremblay
    G Lancman
    E Moshier
    N Bar
    S Jagannath
    A Chari
    Bone Marrow Transplantation, 2017, 52 : 1468 - 1470
  • [6] Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents
    Tremblay, D.
    Lancman, G.
    Moshier, E.
    Bar, N.
    Jagannath, S.
    Chari, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1468 - 1470
  • [7] Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
    Toprak, Selami Kocak
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (03) : 338 - 339
  • [8] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Egerer, G.
    Hose, D.
    Sauer, S.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ONKOLOGIE, 2013, 36 : 152 - 152
  • [9] Impact of Novel Agents on Frequency of Second Salvage Autologous Transplantation in Patients with Multiple Myeloma
    Pathak, Prajwol
    Unnikrishnan, Athira
    Zou, Fei
    Leather, Helen
    Cogle, Christopher R.
    Hsu, Jack W.
    Brown, Randy A.
    Wingard, John R.
    Norkin, Maxim
    BLOOD, 2016, 128 (22)
  • [10] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Sauer, S.
    Egerer, G.
    Hundemer, M.
    Hose, D.
    Kunz, C.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 189 - 195
12345